Related Experiment Videos
A nuclear matrix protein stabilized by lead exposure: current knowledge and future prospects
K R Shelton1, P M Egle, J W Bigbee
1Department of Biochemistry and Molecular Biophysics, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298-0614.
Neurotoxicology
|January 1, 1993
Summary
Lead exposure affects the nuclear protein p32/6.3, a potential marker for early nervous system development. This protein accumulates in the kidney and brain following lead exposure, impacting nuclear structures.
Area of Science:
- Molecular Biology
- Toxicology
- Neuroscience
Background:
- p32/6.3 is a conserved, low-abundance nuclear protein with an unknown fundamental role.
- Few low-abundance nuclear proteins have been identified, and none previously linked to lead exposure.
- p32/6.3 significantly increases in brain and spinal cord during neonatal development, suggesting a role as a developmental marker.
Purpose of the Study:
- To investigate the relationship between the nuclear protein p32/6.3 and lead exposure.
- To explore p32/6.3 as a potential biomarker for lead intoxication and nervous system development.
Main Methods:
- Analysis of p32/6.3 levels in kidney and brain tissue.
- In vitro studies using mouse neuroblastoma 2a cells exposed to lead.
- Microscopic examination of nuclear structures in lead-treated cells.
Main Results:
- p32/6.3 is a major component of lead-induced intranuclear inclusion bodies in the kidney.
- Lead exposure leads to rapid accumulation of p32/6.3 in kidney and inhibits its degradation in neuroblastoma cells.
- Lead exposure increases nuclear envelope invaginations and nuclear bodies in treated cells.
Conclusions:
- p32/6.3 is a novel target of lead toxicity and a potential marker for early lead intoxication.
- Lead may alter p32/6.3 structure or inhibit its degrading protease, affecting nuclear organization.
- p32/6.3's role in nuclear body formation and movement warrants further investigation in the context of lead exposure.